IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 144 filers reported holding IMMUNOVANT INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,272,151 | +70.6% | 59,186 | -15.7% | 0.01% | +75.0% |
| Q2 2023 | $1,331,998 | +140.0% | 70,216 | +96.2% | 0.00% | +100.0% |
| Q1 2023 | $555,010 | -33.8% | 35,784 | -24.2% | 0.00% | -33.3% |
| Q4 2022 | $838,315 | -29.0% | 47,229 | -77.7% | 0.00% | -25.0% |
| Q3 2022 | $1,181,000 | +34.7% | 211,645 | -5.8% | 0.00% | +100.0% |
| Q2 2022 | $877,000 | +16.2% | 224,767 | +63.9% | 0.00% | 0.0% |
| Q1 2022 | $755,000 | +79.8% | 137,100 | +178.1% | 0.00% | +100.0% |
| Q4 2021 | $420,000 | -1.9% | 49,300 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $428,000 | -17.9% | 49,300 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $521,000 | -34.1% | 49,300 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $791,000 | -65.3% | 49,300 | 0.0% | 0.00% | -60.0% |
| Q4 2020 | $2,277,000 | +110.8% | 49,300 | +60.6% | 0.01% | +66.7% |
| Q3 2020 | $1,080,000 | – | 30,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 1,818,371 | $69,807,263 | 24.57% |
| Alpine Global Management, LLC | 1,252,474 | $48,082,477 | 12.15% |
| Logos Global Management LP | 1,600,000 | $61,424,000 | 8.20% |
| Octagon Capital Advisors LP | 1,000,000 | $38,390,000 | 5.90% |
| Perceptive Advisors | 3,814,691 | $146,445,987 | 4.88% |
| COMMODORE CAPITAL LP | 1,000,000 | $38,390,000 | 4.49% |
| Deep Track Capital, LP | 2,797,955 | $107,413,492 | 4.15% |
| Fairmount Funds Management LLC | 750,000 | $28,792,500 | 3.46% |
| Ikarian Capital, LLC | 7,230 | $27,755,970 | 3.34% |
| ACUTA CAPITAL PARTNERS, LLC | 129,000 | $4,952,310 | 3.32% |